COVID-19-induced Brugada phenocopy pattern in a patient with previous myocardial infarction: A case report

Lijiang Ding1, Huayong Jin

  • 1Department of Electrocardiology, Shaoxing People's Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang Province, China.

Medicine
|December 30, 2025
PubMed

Insights

Coronavirus disease 2019 (COVID-19) can mimic heart attacks with electrocardiogram (ECG) changes. Prompt treatment of fever and specific ECG analysis are key to diagnosing and managing COVID-19-induced Brugada phenocopy, preventing misdiagnosis.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Diagnostics

Background:

  • Coronavirus disease 2019 (COVID-19) can induce electrocardiographic (ECG) abnormalities, including ST-segment elevation.
  • These changes may arise from altered cardiac repolarization or delayed depolarization, potentially leading to misdiagnosis.
  • COVID-19 can mimic acute cardiac events, necessitating careful differential diagnosis.

Purpose of the Study:

  • To report a case of Brugada phenocopy triggered by COVID-19 in a patient with coronary artery disease.
  • To emphasize the importance of specific ECG metrics in diagnosing Brugada phenocopy.
  • To highlight appropriate management strategies for this condition.

Main Methods:

  • A 57-year-old male patient with hypertension and prior myocardial infarction presented with COVID-19 symptoms.
  • Electrocardiogram (ECG) revealed ST-segment elevation, and COVID-19 was confirmed via PCR.
  • Diagnosis of Brugada phenocopy was established using specific ECG parameters like the β-angle and r'-wave triangle base duration.

Main Results:

  • The patient received antiplatelet, antipyretic, and antiviral medications.
  • Following treatment, the patient's fever resolved, and repeat ECG showed normalization of ST-segment elevation.
  • The Brugada phenocopy pattern induced by COVID-19 was successfully managed.

Conclusions:

  • Fever-induced Brugada phenocopy should be considered in the differential diagnosis of ST-segment elevation in patients with coronary artery disease.
  • Precise ECG analysis, including β-angle and r'-wave morphology, is vital to prevent misdiagnosis of ST-elevation myocardial infarction.
  • Controlling triggering factors like fever with antipyretics and antivirals is crucial for preventing arrhythmias.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
190
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
295
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
323
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
690
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
229
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
465